Published 2 days ago • loading... • Updated 2 days ago

Screen time, obesity driving diabetes among youngsters: Docs

Assam doctors warn rising screen time, obesity and junk food are driving diabetes in children and teens; GMCH reports 30–40% higher patient inflow.

1 Articles

Times of India

Lean Right

Screen time, obesity driving diabetes among youngsters: Docs

Assam doctors warn rising screen time, obesity and junk food are driving diabetes in children and teens; GMCH reports 30–40% higher patient inflow.

2 days ago·India

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Coverage Details

Total News Sources1

Leaning Left0Leaning Right1Center0Last Updated2 days agoBias Distribution

100% Right

Bias Distribution

100% of the sources lean Right

100% Right

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Times of India broke the news in India 2 days ago on Friday, November 13, 2026.

Sources are mostly out of (0)

Screen time, obesity driving diabetes among youngsters: Docs

1 Articles

1 Articles

Screen time, obesity driving diabetes among youngsters: Docs

Coverage Details

Bias Distribution

Factuality

Ownership

More stories like this

Over 40% of People with Diabetes Unaware of Condition – WHO

Obesity Treatment Has Revolutionized, but Attitudes Have Not – Doctor Says More Bariatric Surgery Should Be Done

Novo's Investigational CagriSema, a GLP-1 and Amylin Analog, Demonstrated ~21% Average Weight Loss with Lower Doses in the REDEFINE 9 Trial, Presented at ObesityWeek® 2026 and Published in The Lancet Diabetes & Endocrinology

Novo's Wegovy® was associated with a reduction in food noise according to real-world studies at ObesityWeek® 2026

Lilly to Present New Data Across Zepbound, Foundayo, EloraTZP and Retatrutide at ObesityWeek 2026, Moving Obesity Care Beyond the Scale

Diabetes Can Affect Teeth and Gums: Know How to Prevent Problems

Similar News Topics

Similar News Topics

More stories like this

Over 40% of People with Diabetes Unaware of Condition – WHO

Obesity Treatment Has Revolutionized, but Attitudes Have Not – Doctor Says More Bariatric Surgery Should Be Done

Novo's Investigational CagriSema, a GLP-1 and Amylin Analog, Demonstrated ~21% Average Weight Loss with Lower Doses in the REDEFINE 9 Trial, Presented at ObesityWeek® 2026 and Published in The Lancet Diabetes & Endocrinology

Novo's Wegovy® was associated with a reduction in food noise according to real-world studies at ObesityWeek® 2026

Lilly to Present New Data Across Zepbound, Foundayo, EloraTZP and Retatrutide at ObesityWeek 2026, Moving Obesity Care Beyond the Scale

Diabetes Can Affect Teeth and Gums: Know How to Prevent Problems

Screen time, obesity driving diabetes among youngsters: Docs

1 Articles

1 Articles

Screen time, obesity driving diabetes among youngsters: Docs

Coverage Details

Bias Distribution Too Big Arrow Icon

Factuality Info Icon

Ownership

More stories like this

Over 40% of People with Diabetes Unaware of Condition – WHO

Obesity Treatment Has Revolutionized, but Attitudes Have Not – Doctor Says More Bariatric Surgery Should Be Done

Novo's Investigational CagriSema, a GLP-1 and Amylin Analog, Demonstrated ~21% Average Weight Loss with Lower Doses in the REDEFINE 9 Trial, Presented at ObesityWeek® 2026 and Published in The Lancet Diabetes & Endocrinology

Novo's Wegovy® was associated with a reduction in food noise according to real-world studies at ObesityWeek® 2026

Lilly to Present New Data Across Zepbound, Foundayo, EloraTZP and Retatrutide at ObesityWeek 2026, Moving Obesity Care Beyond the Scale

Diabetes Can Affect Teeth and Gums: Know How to Prevent Problems

Similar News Topics

Similar News Topics

More stories like this

Over 40% of People with Diabetes Unaware of Condition – WHO

Obesity Treatment Has Revolutionized, but Attitudes Have Not – Doctor Says More Bariatric Surgery Should Be Done

Novo's Investigational CagriSema, a GLP-1 and Amylin Analog, Demonstrated ~21% Average Weight Loss with Lower Doses in the REDEFINE 9 Trial, Presented at ObesityWeek® 2026 and Published in The Lancet Diabetes & Endocrinology

Novo's Wegovy® was associated with a reduction in food noise according to real-world studies at ObesityWeek® 2026

Lilly to Present New Data Across Zepbound, Foundayo, EloraTZP and Retatrutide at ObesityWeek 2026, Moving Obesity Care Beyond the Scale

Diabetes Can Affect Teeth and Gums: Know How to Prevent Problems

Bias Distribution

Factuality